Artificial oocyte activation with CALCIUM IONOPHORE (A+23187) following ICSI fertilization failure

2015 ◽  
Vol 104 (3) ◽  
pp. e302
Author(s):  
A. Sdrigotti ◽  
G.J. Rey Valzacchi ◽  
F.A. Leocata Nieto ◽  
V.E. Canada
2015 ◽  
Vol 32 (3) ◽  
pp. 115-120
Author(s):  
Masahiro Sakurai ◽  
Shinichi Watanabe ◽  
Toyomi Tanaka ◽  
Rie Matsunaga ◽  
Naoko Yamanaka ◽  
...  

2013 ◽  
Vol 30 (12) ◽  
pp. 1569-1575 ◽  
Author(s):  
Hye Jin Yoon ◽  
In Hee Bae ◽  
Hyoung Jun Kim ◽  
Jung Mi Jang ◽  
Yong Su Hur ◽  
...  

2019 ◽  
Vol 39 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Junsheng Li ◽  
Xiaoying Zheng ◽  
Ying Lian ◽  
Ming Li ◽  
Shengli Lin ◽  
...  

2020 ◽  
Vol 26 (2) ◽  
pp. 80-87 ◽  
Author(s):  
Jian Mu ◽  
Zhihua Zhang ◽  
Ling Wu ◽  
Jing Fu ◽  
Biaobang Chen ◽  
...  

Abstract Fertilization involves a series of molecular events immediately following egg–sperm fusion; Ca2+ oscillations are the earliest signaling event, and they initiate the downstream reactions including pronucleus formation. Successful human reproduction requires normal fertilization. In clinical IVF or ICSI attempts, some infertile couples suffer from recurrent fertilization failure. However, the genetic reasons for fertilization failure are largely unknown. Here, we recruited several couples diagnosed with fertilization failure even though their gametes are morphologically normal. Through whole-exome sequencing and Sanger sequencing, we identified biallelic mutations in gene-encoding phospholipase C zeta 1 (PLCZ1) in four independent males in couples diagnosed with fertilization failure. Western blotting showed that missense mutations decreased the level of PLCZ1 and that nonsense or frameshift mutations resulted in undetectable or truncated proteins. Expression of these mutations in mice significantly reduced the levels of oocyte activation. Artificial oocyte activation in patient oocytes could rescue the phenotype of fertilization failure and help establish pregnancy and lead to live birth. Our findings expand the spectrum of PLCZ1 mutations that are responsible for human fertilization failure and provide a potentially feasible therapeutic treatment for these patients.


2009 ◽  
Vol 92 (1) ◽  
pp. 131-136 ◽  
Author(s):  
Edson Borges Jr. ◽  
Daniela Paes de Almeida Ferreira Braga ◽  
Tatiana Carvalho de Sousa Bonetti ◽  
Assumpto Iaconelli Jr. ◽  
José Gonçalves Franco Jr.

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
J Dai ◽  
T Zhang ◽  
J Guo ◽  
Q Zhou ◽  
Y Gu ◽  
...  

Abstract Study question What are the other male factors that cause total fertilization failure (TFF) excepting for variants in PLCZ1? Summary answer Homozygous variants in ACTL9 (actin like 9) cause abnormal localization of PLCζ in a loosened perinuclear theca (PT) structure and leads to TFF. What is known already In previous studies, investigators have reported that the female factors in TFF after intracytoplasmic sperm injection (ICSI) include pathogenic variants in WEE2, TLE6, and TUBB8, whereas for male factors, pathogenic variants in PLCZ1 were reported to be the primary cause of TFF, which account for approximately 30% of couples with male factors in TFF excluding globozoospermia. Most recently, it was reported that pathogenic variants in ACTL7A led to reduced expression and abnormal localization of PLCζ, thereby identifying this genetic variant as a potential cause of TFF. Study design, size, duration Fifty-four infertile couples with TFF or poor fertilization (fertilization rate of < 20%) at the Reproductive and Genetic Hospital of CITIC-Xiangya during January 2014 to June 2020 were recruited into this study. Participants/materials, setting, methods Male factors were identified in (MOAT). WES analysis was used to analyze the genetic factors of individuals with male factors. Sperm morphological study was conducted by H&E staining and TEM. Immunostaining of PLCζ was used to analyze the status of sperm-borne activation factor. A knock-in mouse model was generated by CRISPER-Cas9 technology. Sperm from homozygous Actl9 variant mice were analyzed by TEM and ICSI. ICSI with AOA was performed in couples with ACTL9 variants. Main results and the role of chance A total of 54 couples with TFF or poor fertilization were screened, with 21 couples determined to have a male infertility factor by MOAT. Whole-exome sequencing of these 21 male individuals identified three homozygous pathogenic variants in ACTL9 in three individuals. ACTL9 variations led to abnormal ultrastructure of the PT, with PLCζ absent in the head and present in the neck of the mutant sperm, which contributed to failed normal calcium oscillations in oocytes and subsequent TFF. The key roles of ACTL9 in the PT structure and TFF after ICSI were further confirmed in Actl9-mutated mouse model. Furthermore, assisted oocyte activation by calcium ionophore exposure successfully overcame TFF and achieved live births in a couple with an ACTL9 variant. Limitations, reasons for caution The mechanism of how ACTL9 regulate PLCζ remains unknown. Wider implications of the findings: It provided a genetic marker and a therapeutic option for individuals who have undergone ICSI without successful fertilization. Trial registration number not applioable


Zygote ◽  
2015 ◽  
Vol 24 (2) ◽  
pp. 286-292 ◽  
Author(s):  
Daisuke Yamamoto ◽  
Toshiyuki Yasui ◽  
Chika Kobayashi ◽  
Takane Kitazato ◽  
Takeshi Iwasa ◽  
...  

SummaryThe aim of the present study was to determine the effects of increased dietary intake and high fat diet (HFD) in mice on artificial oocyte activation by using puromycin or roscovitine. Six-week-old mice were fed as either a control diet group, an increased dietary intake group or an HFD group for 4 weeks. Oocytes were obtained following superovulation and were divided into three treatment groups (no activation treatment, calcium ionophore and puromycin treatment, and calcium ionophore and roscovitine treatment) and were incubated for 4 h. Retrieved oocytes and numbers of oocytes activated as assessed by morphological changes were compared among the three treatment groups. The proportion of degenerated oocytes in HFD mice was significantly higher than that in control diet mice. The rates of activation in oocytes treated with roscovitine were 90.3% in control diet mice, 89.8% in increased dietary intake mice and 67.9% in HFD mice. The rate of activation in oocytes treated with roscovitine in HFD mice was significantly lower than the rates in control diet mice and increased dietary intake mice. The rates of activation in oocytes treated with puromycin were 90.6% in control diet mice, 94.0% in increased dietary intake mice and 71.4% in HFD mice, and the rate of activation in oocytes treated with puromycin in HFD mice was significantly lower than the rates in control diet mice and increased dietary intake mice. HFD-induced obesity deteriorated induction of oocyte activation by roscovitine or puromycin in mice.


Sign in / Sign up

Export Citation Format

Share Document